Software Refraction With Mobilerone Versus Retinoscopy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age10-46
SponsorBeijing Airdoc Technology Co., Ltd.
About this trial
Software refraction in the mobilerone for myopia and astigmatism is a novel medical device for myopia adults and elder children with or without astigmatism. And the investigators would like to test its accuracy and efficacy as well as safety.
Eligibility criteria
Qualifiers
• subject with ametropia on each eye ≤-12.00D
subject with best corrected visual acuity ≥ 20/25, no amblyopia
subject with normal transparency of eyes
subject with a healthy fundus that does not reveal major abnormalities that may affect vision due to the fluctuate situations
Disqualifiers
• subject with a topography showing an anomaly (keratoconus type or other)
subject with hyperopia or presbyopia
subject with mild myopia ≥ -1.00D
subject who cannot speak with the operator including those staff of local optometrists or ophthalmologists
Trial design
Treatments tested in this trial
- Software refraction with Eye Test Technology in a mobilerone
- Retinoscopy
Treatment groups
120 Participants
are divided into 2 treatment groupsSponsors and collaborators
Beijing Airdoc Technology Co., Ltd.
Lead sponsor
University of Notre Dame Australia
Collaborator
Source ClinicalTrials.gov